X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8670) 8670
Publication (785) 785
Book Chapter (75) 75
Book Review (51) 51
Dissertation (27) 27
Conference Proceeding (24) 24
Government Document (8) 8
Magazine Article (4) 4
Trade Publication Article (3) 3
Newspaper Article (2) 2
Paper (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
osteoprotegerin (5685) 5685
humans (4601) 4601
index medicus (3756) 3756
animals (3050) 3050
female (2719) 2719
male (2574) 2574
mice (1951) 1951
osteoporosis (1713) 1713
middle aged (1641) 1641
rankl (1429) 1429
receptor activator (1366) 1366
endocrinology & metabolism (1306) 1306
expression (1288) 1288
osteoprotegerin - metabolism (1221) 1221
adult (1220) 1220
aged (1214) 1214
rank ligand (1145) 1145
rank ligand - metabolism (1145) 1145
osteoprotegerin ligand (996) 996
cells, cultured (982) 982
bone (976) 976
differentiation (964) 964
osteoprotegerin - blood (925) 925
cells (892) 892
kappa-b ligand (890) 890
osteoprotegerin - genetics (838) 838
receptor activator of nuclear factor-kappa b (828) 828
osteoclast differentiation (823) 823
osteoclasts - metabolism (817) 817
rats (802) 802
musculoskeletal diseases (796) 796
cell biology (783) 783
osteoclastogenesis (777) 777
bone resorption (761) 761
gene expression (746) 746
receptors, tumor necrosis factor (721) 721
in-vitro (712) 712
biochemistry & molecular biology (709) 709
osteoclasts - cytology (709) 709
osteoclasts (703) 703
osteoblasts (687) 687
osteoblasts - metabolism (677) 677
osteoclast (676) 676
osteoclasts - drug effects (671) 671
postmenopausal women (669) 669
analysis (666) 666
inflammation (664) 664
trance protein (664) 664
ligand (647) 647
dentistry, oral surgery & medicine (633) 633
cytokines (627) 627
bones (617) 617
opg (609) 609
bone density (594) 594
rank ligand - genetics (591) 591
bone-resorption (589) 589
biomarkers - blood (587) 587
rheumatology (580) 580
risk factors (578) 578
dentistry (569) 569
medicine, research & experimental (567) 567
bone and bones - metabolism (541) 541
disease (539) 539
oncology (538) 538
research (510) 510
immunology (507) 507
signal transduction (493) 493
activation (482) 482
orthopedics (475) 475
cell differentiation (474) 474
density (472) 472
osteoclasts - physiology (472) 472
apoptosis (464) 464
rheumatoid-arthritis (464) 464
proteins (463) 463
resorption (452) 452
mice, inbred c57bl (447) 447
enzyme-linked immunosorbent assay (446) 446
ligands (443) 443
biocompatibility (441) 441
osteoblasts - drug effects (440) 440
gene-expression (426) 426
cell differentiation - drug effects (425) 425
bone-mineral density (422) 422
physiological aspects (421) 421
cell line (420) 420
metabolism (412) 412
atherosclerosis (409) 409
bone mineral density (409) 409
osteogenesis (408) 408
bone loss (406) 406
nf-kappa-b (403) 403
rank ligand - blood (400) 400
immunohistochemistry (399) 399
medicine & public health (399) 399
osteoblasts - cytology (392) 392
article (391) 391
rna, messenger - metabolism (391) 391
mineral density (385) 385
osteoblast (383) 383
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8233) 8233
Chinese (184) 184
Japanese (93) 93
Polish (51) 51
German (46) 46
French (35) 35
Korean (30) 30
Spanish (30) 30
Russian (23) 23
Czech (12) 12
Italian (7) 7
Portuguese (7) 7
Turkish (7) 7
Hungarian (5) 5
Croatian (2) 2
Dutch (2) 2
Persian (2) 2
Arabic (1) 1
Danish (1) 1
Indonesian (1) 1
Romanian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Periodontology, ISSN 0303-6979, 03/2012, Volume 39, Issue 3, pp. 239 - 248
Background and Objectives: The receptor activator of NF-kappa B ligand-osteoprotegerin (RANKL-OPG) bi-molecular system is the "bottle-neck" regulator of... 
gingival crevicular fluid | receptor activator of NF‐κB ligand | diagnostics | receptor activator of NF‐κB ligand/osteoprotegerin ratio | osteoprotegerin | periodontal disease | receptor activator of NF-ÎB ligand/osteoprotegerin ratio | receptor activator of NF-ÎB ligand | receptor activator of NF-?B ligand | DIFFERENTIAL EXPRESSION | osteoprotegerin ratio | NECROSIS-FACTOR-ALPHA | TRANSCRIPTION FACTOR NFATC1 | MESSENGER-RNA | DENTISTRY, ORAL SURGERY & MEDICINE | OSTEOPROTEGERIN LIGAND | RECEPTOR ACTIVATOR | OSTEOCLAST DIFFERENTIATION | KAPPA-B LIGAND | ALVEOLAR BONE DESTRUCTION | Alveolar Bone Loss - metabolism | Biomarkers - metabolism | Lymphocytes - metabolism | Alveolar Bone Loss - therapy | RANK Ligand - metabolism | Humans | Periodontitis - therapy | Diabetes Mellitus - metabolism | Periodontitis - blood | Gingival Crevicular Fluid - chemistry | Biomarkers - blood | Saliva - chemistry | Periodontal Ligament - metabolism | Periodontitis - metabolism | Dental Plaque - microbiology | Smoking - metabolism | RANK Ligand - blood | Animals | Gingiva - chemistry | Osteoporosis - metabolism | Osteoprotegerin - blood | Osteoprotegerin - metabolism | Osteoblasts - metabolism | Alveolar Bone Loss - blood | Oral hygiene | Immune system | Diabetes mellitus | biomarkers | Blood | Osteoprotegerin | Bone resorption | Osteoclastogenesis | Periodontal diseases | NF- Kappa B protein | Molecular modelling | Periodontitis | Gingiva | TRANCE protein | Saliva | Smoking
Journal Article
Journal Article
Journal Article
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 12/2014, Volume 34, Issue 12, pp. 2609 - 2616
Journal Article
Vascular Pharmacology, ISSN 1537-1891, 2016, Volume 82, pp. 30 - 40
Abstract Vascular calcification (VC), a disorder that causes blood vessel hardening and dysfunction, is a significant risk factor for type-2 diabetes mellitus... 
Cardiovascular | Vascular calcification | RANKL | TRAIL | Type-2 diabetes mellitus | OPG | SERUM OSTEOPROTEGERIN | AORTIC CALCIFICATION | PLASMA OSTEOPROTEGERIN | APOPTOSIS-INDUCING LIGAND | CORONARY-ARTERY CALCIFICATION | RECEPTOR ACTIVATOR | OSTEOCLASTIC DIFFERENTIATION | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | CHRONIC KIDNEY-DISEASE | KAPPA-B LIGAND | RANK Ligand - metabolism | Humans | Diabetic Angiopathies - etiology | Arteries - metabolism | Atherosclerosis - etiology | Vascular Calcification - metabolism | Diabetic Angiopathies - pathology | Vascular Calcification - etiology | Osteoprotegerin - therapeutic use | Diabetes Mellitus, Type 2 - complications | Diabetic Angiopathies - metabolism | Atherosclerosis - pathology | Osteoclasts - pathology | Atherosclerosis - drug therapy | Signal Transduction | Osteogenesis - drug effects | Arteries - drug effects | Arteries - pathology | Diabetic Angiopathies - drug therapy | Vascular Calcification - drug therapy | Plaque, Atherosclerotic | TNF-Related Apoptosis-Inducing Ligand - metabolism | Vascular Calcification - pathology | Osteoclasts - metabolism | TNF-Related Apoptosis-Inducing Ligand - therapeutic use | Atherosclerosis - metabolism | Cardiovascular Agents - therapeutic use | Osteoblasts - pathology | Animals | RANK Ligand - antagonists & inhibitors | Osteoprotegerin - metabolism | Osteoblasts - metabolism | Type 2 diabetes | Analysis | Atherosclerosis | Venture capital | Physiological aspects | Calcification | Cardiovascular diseases | Health aspects
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 08/2014, Volume 394, Issue 1-2, pp. 13 - 20
Journal Article